PGF and preeclampsia: We found that complementing PlGF with a single metabolite biomarker (DLG) increased the sensitivity of the test from 48% (at PPV = 0.05) to 74% (at PPV = 0.06) for predicting preterm preeclampsia risk in nulliparous women without overt risk factors.